Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rabe

Showing results (291-300 of 646) with videos related to

Pageof 65
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease|February 6, 2020
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE StudiesFernando J Martinez, Klaus F Rabe, Brian J Lipworth, et al.
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Sputum induction in severe asthma by a standardized protocol: predictors of excessive bronchoconstrictionA ten Brinke, C de Lange, A H Zwinderman, et al.
Respiratory Medicine|February 16, 2006
Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthmaIlonka H van Veen, A ten Brinke, A C van der Linden, et al.
Lancet (London, England)|September 1, 2009
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsPeter M A Calverley, Klaus F Rabe, Udo-Michael Goehring, et al.
Proceedings of the American Thoracic Society|December 21, 2012
Reporting and publishing guidelines: article 12 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop reportKevin C Wilson, Richard S Irwin, Thomas M File, et al.
Respiratory Research|October 31, 2013
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialKai M Beeh, Thomas Glaab, Susanne Stowasser, et al.
The European Respiratory Journal|January 6, 2017
Physical activity, airway resistance and small airway dysfunction in severe asthmaThomas Bahmer, Benjamin Waschki, Fee Schatz, et al.
Lancet (London, England)|February 17, 2015
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialFernando J Martinez, Peter M A Calverley, Udo-Michael Goehring, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterolN M Muñoz, K F Rabe, A J Vita, et al.
Respiration; International Review of Thoracic Diseases|November 14, 2017
Physical Activity and Fatigue in Patients with SarcoidosisThomas Bahmer, Henrik Watz, Maria Develaska, et al.
Pageof 65

Showing results (291-300 of 646) with videos related to

Sort By:
Pageof 65
International Journal of Chronic Obstructive Pulmonary Disease|February 6, 2020
Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE StudiesFernando J Martinez, Klaus F Rabe, Brian J Lipworth, et al.
American Journal of Respiratory and Critical Care Medicine|September 11, 2001
Sputum induction in severe asthma by a standardized protocol: predictors of excessive bronchoconstrictionA ten Brinke, C de Lange, A H Zwinderman, et al.
Respiratory Medicine|February 16, 2006
Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthmaIlonka H van Veen, A ten Brinke, A C van der Linden, et al.
Lancet (London, England)|September 1, 2009
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsPeter M A Calverley, Klaus F Rabe, Udo-Michael Goehring, et al.
Proceedings of the American Thoracic Society|December 21, 2012
Reporting and publishing guidelines: article 12 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop reportKevin C Wilson, Richard S Irwin, Thomas M File, et al.
Respiratory Research|October 31, 2013
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialKai M Beeh, Thomas Glaab, Susanne Stowasser, et al.
The European Respiratory Journal|January 6, 2017
Physical activity, airway resistance and small airway dysfunction in severe asthmaThomas Bahmer, Benjamin Waschki, Fee Schatz, et al.
Lancet (London, England)|February 17, 2015
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialFernando J Martinez, Peter M A Calverley, Udo-Michael Goehring, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1995
Paradoxical blockade of beta adrenergically mediated inhibition of stimulated eosinophil secretion by salmeterolN M Muñoz, K F Rabe, A J Vita, et al.
Respiration; International Review of Thoracic Diseases|November 14, 2017
Physical Activity and Fatigue in Patients with SarcoidosisThomas Bahmer, Henrik Watz, Maria Develaska, et al.
Pageof 65